CSIMarket
 


Zimmer Biomet Holdings Inc   (ZBH)
Other Ticker:  
 
 

ZBH's Operating Income Growth by Quarter and Year

Zimmer Biomet Holdings Inc 's Operating Income results by quarter and year




ZBH Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -28.30 79.10 240.70
III Quarter September 266.60 245.30 214.90 299.20
II Quarter June 329.60 280.90 220.50 -171.70
I Quarter March 327.30 198.40 265.60 -456.00
FY   923.50 696.30 780.10 -87.80



ZBH Operating Income third quarter 2023 Y/Y Growth Comment
Zimmer Biomet Holdings Inc reported Operating Income growth of 8.68% year on year in the third quarter 2023, to $ 266.60 millions, this is lower than Zimmer Biomet Holdings Inc 's recent average Operating Income surge of 683.11%.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 17 other companies have achieved higher Operating Income growth. While Zimmer Biomet Holdings Inc ' s Operating Income increase of 8.68% ranks overall at the positon no. 771 in the third quarter 2023.

Explain Operating Income growth


ZBH Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - -67.14 % -28.53 %
III Quarter September 8.68 % 14.15 % -28.18 % 21.72 %
II Quarter June 17.34 % 27.39 % - -
I Quarter March 64.97 % -25.3 % - -
FY   - -10.74 % - -

Financial Statements
Zimmer Biomet Holdings Inc 's third quarter 2023 Operating Income $ 266.60 millions ZBH's Income Statement
Zimmer Biomet Holdings Inc 's third quarter 2022 Operating Income $ 245.30 millions Quarterly ZBH's Income Statement
New: More ZBH's historic Operating Income Growth >>


ZBH Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - -63.19 % -19.55 %
III Quarter September -19.11 % -12.67 % -2.54 % -
II Quarter June 0.7 % 41.58 % -16.98 % -
I Quarter March - 150.82 % 10.34 % -
FY (Year on Year)   - -10.74 % - -




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #18
Healthcare Sector #43
Overall #771

Operating Income Y/Y Growth Statistics
High Average Low
11245.78 % 683.11 % -107.72 %
(Sep 30 2021)   (Dec 31 2020)
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #18
Healthcare Sector #43
Overall #771
Operating Income Y/Y Growth Statistics
High Average Low
11245.78 % 683.11 % -107.72 %
(Sep 30 2021)   (Dec 31 2020)

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Zimmer Biomet Holdings Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
150.82 % 3.7 % -63.19 %
(Mar 31 2022)  


ZBH's III. Quarter Q/Q Operating Income Comment
In the III. Quarter 2023 Zimmer Biomet Holdings Inc realized fall in Operating Income from the previous quarter by -19.11% to $ 266.60 millions, from $ 329.60 millions achived in the previous quarter.

If you look into recent slump at the III. Quarter, you must presume, that commonly III. Quarter 2023 results emerge softer then in the second quarter

Within Medical Equipment & Supplies industry 36 other companies have achieved higher Operating Income quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Operating Income growth quarter on quarter, overall rank is 1300.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #37
Healthcare Sector #91
Overall #1300
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #37
Healthcare Sector #91
Overall #1300
Operating Income Q/Q Growth Statistics
High Average Low
150.82 % 3.7 % -63.19 %
(Mar 31 2022)  


ZBH's III. Quarter Q/Q Operating Income Comment
In the III. Quarter 2023 Zimmer Biomet Holdings Inc reported fall in Operating Income from the previous quarter by -19.11% to $ 266.60 millions, from $ 329.60 millions released in the previous reporting period.

This is not huge concern, as Zimmer Biomet Holdings Inc 's Operating Income frequently seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 36 other companies have achieved higher Operating Income quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Operating Income growth quarter on quarter, overall rank is 1300.


Zimmer Biomet Holdings Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Operating Income 12 Months Ending $ 895.20 $ 873.90 $ 825.20 $ 696.30 $ 803.70
Y / Y Operating Income Growth (TTM) 11.38 % 13.01 % 15.75 % -10.74 % -14.65 %
Year on Year Operating Income Growth Overall Ranking # 1480 # 1591 # 349 # 880 # 1392
Seqeuential Operating Income Change (TTM) 2.44 % 5.9 % 18.51 % -13.36 % 3.93 %
Seq. Operating Income Growth (TTM) Overall Ranking # 1072 # 929 # 527 # 1535 # 918




Cumulative Operating Income growth Comment
With the quarterly Operating Income reported in the Sep 30 2023 period, Zimmer Biomet Holdings Inc 's cumulative twelve months Operating Income were $ 895 millions, company would post below average annual Operating Income growth of 3.93% year on year, if the fiscal year would end at Sep 30 2023.
A slow-down in the Zimmer Biomet Holdings Inc 's Operating Income growth from the 329.6% growth in Jun 30 2023.

In the Healthcare sector 87 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 1480, from total ranking in previous quarter at 1591.

Operating Income TTM Q/Q Growth Statistics
High Average Low
11245.78 %
683.11 %
-107.72 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 25
Healthcare Sector # 88
Overall # 1480

Operating Income TTM Y/Y Growth Statistics
High Average Low
11245.78 %
683.11 %
-107.72 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 59
S&P 500 # 1072
Cumulative Operating Income growth Comment
With the quarterly Operating Income reported in the Sep 30 2023 period, Zimmer Biomet Holdings Inc 's cumulative twelve months Operating Income were $ 895 millions, company would post below average annual Operating Income growth of -107.72% year on year, if the fiscal year would end at Sep 30 2023.
A slow-down in the Zimmer Biomet Holdings Inc 's Operating Income growth from the 329.6% growth in Jun 30 2023.

In the Healthcare sector 87 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 1480, from total ranking in previous quarter at 1591.

Operating Income TTM Q/Q Growth Statistics
High Average Low
11245.78 %
683.11 %
-107.72 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 25
Healthcare Sector # 88
Overall # 1480

Operating Income TTM Y/Y Growth Statistics
High Average Low
11245.78 %
683.11 %
-107.72 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 59
S&P 500 # 1072




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ZBH's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ZBH's Competitors
Operating Income Growth for Zimmer Biomet Holdings Inc 's Suppliers
Operating Income Growth for ZBH's Customers

You may also want to know
ZBH's Annual Growth Rates ZBH's Profitability Ratios ZBH's Asset Turnover Ratio ZBH's Dividend Growth
ZBH's Roe ZBH's Valuation Ratios ZBH's Financial Strength Ratios ZBH's Dividend Payout Ratio
ZBH's Roa ZBH's Inventory Turnover Ratio ZBH's Growth Rates ZBH's Dividend Comparisons



Companies with similar Operating Income fall for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2023
Encompass Health Corporation14.02%$ 14.021 millions
Idexx Laboratories Inc12.44%$ 12.439 millions
Envista Holdings Corporation11.81%$ 11.812 millions
Surgery Partners Inc 11.47%$ 11.471 millions
Medpace Holdings Inc 9.10%$ 9.098 millions
Zoetis Inc 9.07%$ 9.066 millions
Zimmer Biomet Holdings Inc 8.68%$ 8.683 millions
Amedisys Inc8.43%$ 8.425 millions
Hca Healthcare Inc 7.79%$ 7.787 millions
Chemed Corporation7.41%$ 7.412 millions
Ensign Group Inc7.41%$ 7.410 millions
Dariohealth Corp 6.68%$ 6.677 millions
U S Physical Therapy Inc6.62%$ 6.620 millions
Halozyme Therapeutics Inc 5.99%$ 5.987 millions
5.73%$ 5.727 millions
Resmed Inc 4.81%$ 4.808 millions
Prestige Consumer Healthcare Inc 4.58%$ 4.581 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com